Chord Therapeutics
Latest round
- Series A
Last raised
- Oct 2020
Total raised
- $16M
Investors
- 2
About Chord Therapeutics
Founded in 2014 and headquartered in Geneva, Switzerland, Chord Therapeutics SA specializes in creating advanced therapeutic solutions for rare diseases.Chord Therapeutics designs and develops innovative treatments specifically targeted at rare and challenging neurological conditions.Chord Therapeutics generates revenue through strategic partnerships with healthcare institutions and pharmaceutical companies. Its business model focuses on direct sales agreements, allowing healthcare providers to acquire its treatments for distribution to patients diagnosed with rare neurological disorders.As part of its strategy for future growth, Chord Therapeutics plans to introduce new therapeutic products targeting rare neurological disorders, although specific release dates have not been shared.00 mn to support these initiatives. Following its acquisition by Merck KGaA, Chord Therapeutics is positioned to enhance its capabilities and expand its reach within the pharmaceutical landscape.
Who invested in Chord Therapeutics
2 investors across 2 rounds
See all investors in Chord Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Chord Therapeutics
Who invested in Chord Therapeutics?
Chord Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chord Therapeutics raised?
Chord Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Chord Therapeutics last raise money?
Chord Therapeutics's most recent round on record is a Series A, in Oct 2020.
What does Chord Therapeutics do?
Founded in 2014 and headquartered in Geneva, Switzerland, Chord Therapeutics SA specializes in creating advanced therapeutic solutions for rare diseases.
Where is Chord Therapeutics headquartered?
Chord Therapeutics is headquartered in Geneva, Switzerland.
Which VCs invest in companies like Chord Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Chord Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Chord Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.